购物车
- 全部删除
- 您的购物车当前为空
TGX-115是一种细胞渗透性和有效的PI 3-K 异构体p110β/p110δ抑制剂(对p110β IC50值为 0.13 μM, 对p110δ值为0.63 μM),是一种调节血小板粘附过程的酶,可抑制磷酸肌苷(PI)3-激酶,可用来治疗冠状动脉闭塞、中风、急性冠状动脉综合征、急性心肌梗塞、血管再狭窄、动脉硬化和不稳定心绞痛等心血管疾病 。
为众多的药物研发团队赋能,
让新药发现更简单!
TGX-115是一种细胞渗透性和有效的PI 3-K 异构体p110β/p110δ抑制剂(对p110β IC50值为 0.13 μM, 对p110δ值为0.63 μM),是一种调节血小板粘附过程的酶,可抑制磷酸肌苷(PI)3-激酶,可用来治疗冠状动脉闭塞、中风、急性冠状动脉综合征、急性心肌梗塞、血管再狭窄、动脉硬化和不稳定心绞痛等心血管疾病 。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,350 | 现货 | |
5 mg | ¥ 5,630 | 现货 | |
10 mg | ¥ 7,790 | 现货 | |
25 mg | ¥ 11,200 | 现货 | |
50 mg | ¥ 13,800 | 现货 | |
100 mg | ¥ 17,500 | 现货 | |
500 mg | ¥ 34,800 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 4,660 | 现货 |
产品描述 | TGX-115 is a cell-permeable and potent inhibitor of the PI 3-K isoform p110β/p110δ (IC50 values of 0.13 μM for p110β and 0.63 μM for p110δ), an enzyme that regulates platelet adhesion and inhibits phosphoinositide (PI) 3-kinase, and can be used to treat coronary artery occlusion, stroke, acute coronary artery It can be used to treat cardiovascular diseases such as coronary occlusion, stroke, acute coronary syndrome, acute myocardial infarction, restenosis, atherosclerosis and unstable angina. |
别名 | TGX 115 |
分子量 | 336.38 |
分子式 | C20H20N2O3 |
CAS No. | 351071-62-0 |
Smiles | CC1=CC=CC=C1OC1=CC=CC2=C1NC(=CC2=O)N1CCOCC1 |
密度 | 1.249 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 22.5 mg/mL (66.89 mM) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容